Surrey Heartlands

Joint Formulary & PAD

Pregabalin - Restless Leg Syndrome

You are here : Home > Formulary Search > Pregabalin - Restless Leg Syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Preferred
Patients with severe sleep disturbance, RLS-related / co-morbid pain or history of impulse control disorder

Documentation

Evidence Review
Restless leg syndrome - APC Paper - November 2018
Safety Information
Pregabalin Safety Messages - GP Version - SABP Aug 2020 (updated Mar 2021)
Information
Pregabalin and Gabapentin - Advice for prescribers on risk of misuse - December 2014

PAD Profile

ChemicalSubstance :
Pregabalin
Indication :
Restless Leg Syndrome
Group Name :
Keywords :
Brand Names Include :
Lyrica
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Pregabalin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Restless Leg Syndrome.

Committee Recommendations (1)

07 Nov 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Pregabalin is recommended as a FIRST line option for the treatment of Restless Leg Syndrome, as per CKS guidance.

Link to CKS page - https://cks.nice.org.uk/restless-legs-syndrome  

Please note; this is an off-label indication of a licensed medicine.